Zentalis Pharmaceuticals (ZNTL) Receivables - Net (2019 - 2024)
Zentalis Pharmaceuticals' quarterly Receivables - Net came in at $5.0 million in Q4 2024, up 124900.0% quarter-over-quarter from $4000.0 in Q4 2021.
Zentalis Pharmaceuticals has reported Receivables - Net for 4 years, with the latest figure at $5.0 million in Q4 2024.
- For the quarter ending Q4 2024, Receivables - Net changed N/A year-over-year to $5.0 million; the trailing twelve-month figure through Dec 2024 stood at $5.0 million (changed N/A YoY), and the FY2024 full-year result was $5.0 million, changed N/A from the prior year.
- Receivables - Net for Q4 2024 stood at $5.0 million, up from $4000.0 in the prior quarter.
- The five-year high for Receivables - Net was $5.0 million in Q4 2024, with the low at $4000.0 in Q4 2021.
- Average Receivables - Net over 3 years is $679555.6, with a median of $122000.0 recorded in 2020.
- Year-over-year, Receivables - Net soared 197.86% in 2020 and sank 99.04% in 2021.
- Tracing ZNTL's Receivables - Net over 3 years: stood at $417000.0 in 2020, then slumped by 99.04% to $4000.0 in 2021, then jumped by 124900.0% to $5.0 million in 2024.
- The last three Receivables - Net figures came in at $5.0 million (Q4 2024), $4000.0 (Q4 2021), and $108000.0 (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Zentalis Pharmaceuticals | 280.35 Mn | 280.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2021 | 4,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 108,000.00 |
| Sep 30, 2021 | 108,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 248,000.00 |
| Mar 31, 2021 | 248,000.00 |
| Dec 31, 2020 | 417,000.00 |
| Dec 31, 2020 | 417,000.00 |
| Sep 30, 2020 | 122,000.00 |
| Sep 30, 2020 | 122,000.00 |
| Jun 30, 2020 | 73,000.00 |
| Jun 30, 2020 | 73,000.00 |
| Mar 31, 2020 | 139,000.00 |
| Mar 31, 2020 | 139,000.00 |
| Dec 31, 2019 | 140,000.00 |
| Dec 31, 2019 | 140,000.00 |